ArticleBioMedicine2026
Traditional Chinese herbal medicines suppress endometriosis development through modulating macrophage-mediated immune responses in the peritoneal cavity.
Article in BioMedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Due to unique dietary culture, Asian patients with endometriosis usually seek assistance through traditional Chinese herbal medicine (TCHM), making combined treatments of Western and Chinese medicine quite common in Asia. However, limited molecular evidence has been provided to demonstrate the therapeutic benefits of TCHM in treating endometriosis. Aims: To investigate the functional impacts of TCHM treatment in their traditional formulae on peritoneal immunity, lesion growth, and adhesion formation, we performed studies by using a disease mouse model that exhibits the features of blood stasis and stagnation. Methods: Four well-known TCHM formulae, frequently used for treating symptoms similar to endometriosis, were applied to a mouse model with human endometriosis features. Lesion growth, modulation of peritoneal immune responses, pain-associated behaviors, and endometriosis adhesion were analyzed after TCHM treatment. Results: Among the formulae, Danggui Buxue Tang (DBT) and Shaofu Zhuyu Tang (SZT) can promote blood circulation into the peritoneal cavity, resulting in increased large (LpMs) and small (SpMs) peritoneal macrophages with M1 phenotype polarization. Macrophage activation restrained lesion formation, chronic inflammation, and nerve fiber growth in the treated mice. Behavioral studies further confirmed pain-relief effects that enhanced spontaneous locomotor activity and reduced evoked mechanical hyperalgesia. Interestingly, DBT and SZT treatments can also downregulate the expression of key adhesion molecules, such as ICAM-1 and AKAP12, in the lesions, leading to reduced endometriosis adhesion in treated mice. Conclusion: These findings reveal the functional effects of TCHM formulae, especially DBT and SZT, on macrophage-mediated immune responses in the peritoneal cavity, which may benefit patients with endometriosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.